You should consider shares of Verra Mobility Corporation (NASDAQ:VRRM) and Guardion Health Sciences Inc. (NASDAQ:GHSI) if you are looking for a great stocks to invest in. Starting with the VRRM shares, which traded at $14.91 at the close of the recent session, gaining 0.88%. On Tuesday, the company’s shares shed $0.13 from its value which represented in intraday trading. The stock is now 49.10% higher in year-to-date (YTD) trading. VRRM’s intraday high was $14.95 while its lowest price touched $14.59. The stock’s 52-week high price is $15.35, which means the current price is at -2.90%. In terms of trading activity, the daily trading volume rose to 3178669 against 200-day average trading volume of 1,073,279 shares.
What are analyst forecasts for Verra Mobility Corporation (NASDAQ:VRRM)?
At a consensus rating of 5.00, VRRM is trending as a streaking Strong Buy, as it has been the case a month ago when 5 analysts called it a Strong Buy. Two months ago, 5 analysts recommended, on average, that VRRM stock is a Strong Buy. The Services company’s shares’ overall bullish trend saw it close higher on Tuesday compared to its opening price of $14.67 on the day.
Forecasts for Verra Mobility Corporation (NASDAQ:VRRM) give the stock a fair value for the growth of 14.8% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $17.50, which means the price per share could rise by nearly $2.59. The price range target is between a low of $16.00 and a high of $18.50. The stock would need to gain by about $19.41 to hit the estimated high or 0.6% from its 12-month low.
The consensus among 7 analysts is that it is a good time for one to Buy in the Verra Mobility Corporation. 6 analysts rate VRRM as a Buy, with 0 of 7 analysts rate it as a Sell. 1 have valued the stock as Overweight and 0 have recommended that investors Hold.
Verra Mobility Corporation (NASDAQ:VRRM) Upgrades and Downgrades
In terms of rating changes, BofA/Merrill on September 30, 2019, Upgrade Verra Mobility Corporation (VRRM) at Buy. They believe the stock could reach $16 in the near term. Analysts at Goldman have assigned a Neutral rating for the stock in their research note on July 31, 2019 with an estimated price target of $15. Moreover, BofA/Merrill analysts issued a rating of Neutral for the stock on July 22, 2019, giving it a price target of $14.50 for the next 12 months. On June 28, 2019, the stock earned a Outperform rating due to an analyst call from Robert W. Baird, while analysts from William Blair on April 24, 2019 suggested that the stock is Outperform.
Guardion Health Sciences Inc. (NASDAQ:GHSI) adds -$0.01 on Tuesday
The GHSI stock has tanked -94.57% year-to-date and is currently trading at $0.20, which is -95.00% below its 52-week high. The company shares lost -4.98% on the day and have risen nearly 21.21% off a low hit. At current levels, Guardion Health Sciences Inc. has a valuation of about $0.90M. As of 12/03/19, this stock has fallen -10.71% during the week and closed at $0.21 in the previous session. However, recent Guardion Health Sciences Inc. stock performance shows that GHSI shares are -25.93% down over the last month, and -22.24% down for the last three months.
Who owns shares in Guardion Health Sciences Inc. (GHSI)?
Virtu Financial LLC tops the list of institutional owners as it is holding 34111.0 shares or 0.05% of shares outstanding. Two Sigma Securities, LLC and HRT Financial LLC held 24947.0 and 12546.0 representing 0.03% and 0.02% respectively at the close of the last trading session. As of Sep 29, 2019, UBS Group AG accounted for 8302.0 shares at over 6327.0. This represented 0.01% of shares outstanding.